Skip to content
CNS Clinical Research

Georgia

CNS clinical trials in Georgia

139 CNS studies are recruiting participants at sites in 23 cities across Georgia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Georgia by city

Cities with the most studies recruiting right now.

Every Georgia city with a recruiting study

By research area: Depression (50), Schizophrenia (30), Parkinson's Disease (17), Migraine (14), Multiple Sclerosis (11), Bipolar Disorder (6), Epilepsy (6), ADHD (5).

Atlanta (90), Decatur (33), Savannah (18), Augusta (11), Snellville (10), Marietta (7), Athens (4), Norcross (4), Peachtree Corners (4), Stone Mountain (4), Smyrna (3), Stockbridge (3), Brunswick (2), Lawrenceville (2), Newnan (2), Albany (1), Austell (1), Fayetteville (1), Hinesville (1), Johns Creek (1), Rome (1), Sandy Springs (1), Union City (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Georgia

Basic details from each study's public record (the 12 most recently updated of 139). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Atlanta · Decatur
    Registry record
    NCT07226661 · updated
  2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Recruiting in
    Marietta
    Registry record
    NCT06793397 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Georgia on ClinicalTrials.gov.

Schizophrenia: recently updated in Georgia

  1. Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    Minerva Neurosciences
    Recruiting in
    Atlanta · Decatur
    Registry record
    NCT07565428 · updated
  2. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Augusta · Snellville
    Registry record
    NCT06887192 · updated
  3. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Atlanta · Lawrenceville · Stone Mountain
    Registry record
    NCT07288567 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Georgia on ClinicalTrials.gov.

ADHD: recently updated in Georgia

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Atlanta
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Georgia on ClinicalTrials.gov.

Parkinson's disease: recently updated in Georgia

  1. Adaptango Performance PRocess for Older Adults Community reHabilitation

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Recruiting in
    Atlanta
    Registry record
    NCT07824128 · updated
  2. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Athens
    Registry record
    NCT06841354 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Georgia on ClinicalTrials.gov.

Epilepsy: recently updated in Georgia

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT07563881 · updated
  2. A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

    • Phase 2/3
    • Ages 10 and older
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Savannah
    Registry record
    NCT07723963 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Georgia on ClinicalTrials.gov.

Migraine: recently updated in Georgia

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Atlanta · Decatur
    Registry record
    NCT07616128 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Atlanta · Norcross · Savannah
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Georgia on ClinicalTrials.gov.

Ask about studies in Georgia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call